Riera, P.; RodrÃguez-Santiago, B.; Lasa, A.; Gonzalez-Quereda, L.; MartÃn, B.; Salazar, J.; Sebio, A.; Virgili, A.C.; Minguillón, J.; Camps, C.;
et al. Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients. Cancers 2020, 12, 2245.
https://doi.org/10.3390/cancers12082245
AMA Style
Riera P, RodrÃguez-Santiago B, Lasa A, Gonzalez-Quereda L, MartÃn B, Salazar J, Sebio A, Virgili AC, Minguillón J, Camps C,
et al. Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients. Cancers. 2020; 12(8):2245.
https://doi.org/10.3390/cancers12082245
Chicago/Turabian Style
Riera, Pau, BenjamÃn RodrÃguez-Santiago, Adriana Lasa, Lidia Gonzalez-Quereda, Berta MartÃn, Juliana Salazar, Ana Sebio, Anna C. Virgili, Jordi Minguillón, Cristina Camps,
and et al. 2020. "Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients" Cancers 12, no. 8: 2245.
https://doi.org/10.3390/cancers12082245
APA Style
Riera, P., RodrÃguez-Santiago, B., Lasa, A., Gonzalez-Quereda, L., MartÃn, B., Salazar, J., Sebio, A., Virgili, A. C., Minguillón, J., Camps, C., Surrallés, J., & Páez, D.
(2020). Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients. Cancers, 12(8), 2245.
https://doi.org/10.3390/cancers12082245
